Early Intervention to Promote Return to Work for People With Spinal Cord Injury
Launched by KESSLER FOUNDATION · Aug 17, 2022
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how to best help people with spinal cord injuries find jobs after their rehabilitation. Many individuals with these injuries want to get back to work, but we don’t yet know the most effective ways to support them in achieving this goal. The study will compare two different approaches to organizing and delivering services that assist people with spinal cord injuries in obtaining employment.
To participate in this trial, you need to be an adult between the ages of 18 and 62, have a spinal cord injury that happened less than a year ago, and be receiving rehabilitation at the Kessler Institute for Rehabilitation in New Jersey. You should also have a goal of finding a job or furthering your education to help you get a job. If you join the study, you will be part of a program designed to help you achieve your employment goals. This trial is not yet recruiting participants, but it aims to improve the support available for those with spinal cord injuries who want to return to work.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adults age 18 to 62
- • a neurological impairment secondary to an SCI that occurred less than 12 months prior to enrollment
- • receiving inpatient rehabilitation at Kessler Institute for Rehabilitation (KIR)
- • community living in the state of NJ after discharge from KIR
- • have a goal to pursue competitive integrated employment or education/retraining leading to competitive integrated employment
About Kessler Foundation
Kessler Foundation is a leading nonprofit organization dedicated to advanced rehabilitation research and the development of innovative strategies to improve the lives of individuals with disabilities. With a strong emphasis on clinical trials and evidence-based practices, the Foundation collaborates with academic institutions, healthcare providers, and industry partners to explore novel therapeutic approaches and technologies. Its commitment to enhancing mobility, cognitive function, and overall quality of life for people with neurological and musculoskeletal conditions drives its mission to transform rehabilitation outcomes through cutting-edge research and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Trevor Dyson-Hudson, M.D.
Principal Investigator
Kessler Foundation
John O'Neill, Ph.D.
Principal Investigator
Kessler Foundation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials